Ascendis Pharma Receivables 2015-2024 | ASND
- Ascendis Pharma receivables for 2023 were $0.06B, a 123.57% increase from 2022.
- Ascendis Pharma receivables for 2022 were $0.027B, a 1.57% decline from 2021.
- Ascendis Pharma receivables for 2021 were $0.027B, a 226.99% increase from 2020.